Subject: CIIX Executes LOI for Exclusive Licensing Agreement

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
CIIX Executes LOI for Exclusive Licensing Agreement
Hot Stock to WatchHot Stock to Watch

Company: (OTCQB: CIIX)


Price: 0.58

Change (%): - 0.03 (4.92)

Volume: 111,041
CIIX Chart, Inc. Executes Letter of Intent for Exclusive Licensing Agreement for VitaMist's 100% Natural, Non-GMO, Organic Product Line Owned by BCBDG, Inc.

SAN GABRIEL, California, December 4, 2018 /PRNewswire/ -, Inc. (OTCQB: CIIX) (“CIIX” or “the Company”), a premier provider of industrial, hemp-derived CBD products and other hemp health products for the global Chinese community, today announced that it recently executed a letter of intent to acquire exclusive rights to all sales channels for the VitaMist product line (retail, online, MLM) in Asian markets domestically and internationally. As part of the proposed licensing agreement, BCDBG, Inc. will also develop an exclusive product line, for, Inc. designed with the global Asian Market in mind, including vitamin only sprays and vitamins/CBD spray combinations. In furtherance of the anticipated agreement, the Company has placed initial product orders with BCDBG, Inc. for VitaMist products. The timing of this agreement for licensing and product development is critical as some industry leaders believe that a final farm bill, including provisions for the legalization of industrial hemp at a federal level, is expected to reach completion this week or by the end of the year.

BCBDG, Inc. recently acquired VitaMist Ltd. and Mayor Pharmaceutical Laboratories, Inc., known for their development and distribution of spray delivery vitamins, with over 30 years in the industry and over three million individual product sales. VitaMist Ltd. was awarded the first patent ever for a spray vitamin in 1985.

“The licensing agreement with BCBDG, Inc. will be a significant development for, Inc.’s consumer division as we expand our product line globally and capitalize on VitaMist’s innovative spray technology, over 40 proprietary vitamin formulas, its brand recognition and its longevity in the industry. We truly believe VitaMist’s innovative and effective delivery system is the future for CBD consumption.” says, Inc.’s CEO, Warren Wang.

Wang continues, “With South Korea becoming the first East Asian country to legalize marijuana for medical purposes, and with hopes that Thailandwill soon follow, this is an exciting time for the global cannabis industry as well. We look forward to more opportunities such as this licensing offer as we expand our reach into global industrial hemp industry.”

Continue Reading

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks